Wells Fargo & Company Regeneron Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 174,041 shares of REGN stock, worth $128 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
174,041
Previous 156,536 11.18%
Holding current value
$128 Million
Previous $165 Million 11.2%
% of portfolio
0.04%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $17.9 Million - $21 Million
17,505 Added 11.18%
174,041 $183 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $26.3 Million - $31.9 Million
29,818 Added 23.53%
156,536 $165 Million
Q1 2024

May 10, 2024
BUY
$902.69 - $993.35 $7.48 Million - $8.23 Million
8,284 Added 6.99%
126,718 $122 Million
Q4 2023

Feb 09, 2024
BUY
$775.18 - $881.7 $1.45 Million - $1.65 Million
1,870 Added 1.6%
118,434 $104 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $16.7 Million - $20.4 Million
-24,171 Reduced 17.17%
116,564 $95.9 Million
Q2 2023

Aug 15, 2023
SELL
$700.03 - $830.35 $4.11 Million - $4.88 Million
-5,872 Reduced 4.01%
140,735 $101 Million
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $7.06 Million - $8.58 Million
-10,370 Reduced 6.61%
146,607 $120 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $9.99 Million - $10.8 Million
-14,152 Reduced 8.27%
156,977 $113 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $16.1 Million - $20.3 Million
-27,969 Reduced 14.05%
171,129 $118 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $16 Million - $21.6 Million
-29,212 Reduced 12.79%
199,098 $118 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $15.8 Million - $18.5 Million
26,495 Added 13.13%
228,310 $159 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $36.8 Million - $45.5 Million
-67,766 Reduced 25.14%
201,815 $127 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $510,886 - $606,054
-890 Reduced 0.33%
269,581 $163 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $949,382 - $1.12 Million
2,008 Added 0.75%
270,471 $151 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $27.3 Million - $33.5 Million
-61,198 Reduced 18.56%
268,463 $127 Million
Q4 2020

Feb 09, 2021
SELL
$478.3 - $607.98 $14.5 Million - $18.4 Million
-30,323 Reduced 8.42%
329,661 $159 Million
Q3 2020

Nov 05, 2020
BUY
$544.75 - $658.21 $27.5 Million - $33.2 Million
50,493 Added 16.31%
359,984 $202 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $42.4 Million - $55.3 Million
85,885 Added 38.41%
309,491 $193 Million
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $75.2 Million - $111 Million
223,606 New
223,606 $109 Million

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email